Nobiretic (Hydrochlorothiazide, Nebivolol)

Hydrochlorothiazide and Nebivolol, the active ingredients in Nobiretic, are a thiazide diuretic and β1‑selective blocker combination presented as an oral tablet for oral use. The product is indicated for the treatment of hypertension in adult patients, helping to lower elevated blood pressure and reduce cardiovascular risk.

GNH USA supplies Nobiretic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable global distribution, ensuring product integrity throughout the supply chain.

Nobiretic, a combined thiazide diuretic and β1‑selective blocker, is used in the management of high blood pressure.

- Essential hypertension: reduces systolic and diastolic pressure to target levels. - Secondary hypertension: assists in controlling blood pressure when caused by renal or endocrine disorders. - Hypertension with concomitant heart failure: helps lower pressure while providing β‑blockade benefits.

Nobiretic may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate pain in the head region. - Fatigue: feeling unusually tired or weak. - Increased urination: more frequent need to void. - Dry mouth: reduced salivary flow causing discomfort. - Mild gastrointestinal discomfort: nausea or abdominal upset.

Serious or Rare Side Effects: - Severe electrolyte disturbance: abnormal potassium or sodium levels requiring medical attention. - Acute renal failure: sudden loss of kidney function. - Significant bradycardia: heart rate dropping below normal limits. - Hypotension: markedly low blood pressure that may cause fainting.

When prescribing Nobiretic, clinicians should consider several precautionary measures to ensure patient safety.

- Monitor electrolytes: check serum potassium and sodium regularly. - Assess renal function: evaluate creatinine clearance before and during therapy. - Avoid abrupt discontinuation: taper dose to prevent rebound hypertension. - Caution in gout patients: diuretic component may increase uric acid levels. - Use with caution in severe hepatic impairment: drug metabolism may be altered. - Store at room temperature: keep in the original pack, protect from moisture.

Nobiretic can interact with other medicines, requiring careful assessment of concomitant therapy.

Major Interactions (Avoid): - Concurrent use with other diuretics: risk of excessive volume depletion. - Combined with ACE inhibitors or ARBs: may increase risk of renal dysfunction. - Co‑administration with potassium‑sparing agents: risk of hyperkalaemia.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce antihypertensive effect. - Other β‑blockers or β‑agonists: may diminish nebivolol efficacy. - Lithium: may increase lithium serum concentrations, requiring monitoring.